Potential ‘Functional Cure’ for AIDS?
March 7, 2014 | Clinician Reviews
Author and Disclosure Information
Major finding: Three of 12 HIV-positive patients treated with modified autologous T cells had viral load reductions between 0.8 and 1.9 log10 after 16 weeks of antiretroviral therapy interruption.
Data source: Phase I/II dose-escalation study in 12 patients.
Disclosures: The study was supported by Sangamo Biosciences. Dr. Blick, Dr.Kay and Dr. Walker reported having no relevant financial disclosures.
FROM CROI 2014
Is this elegant science? Yes. Is it an important step in the right direction? Yes. Will this turn out to be a successful approach? I can’t tell you that right now. It might not be.
Dr. Fauci is director of the National Institute of Allergy and Infectious Diseases in Bethesda, Md.
